
==== Front
BioDrugsBioDrugsBiodrugs1173-88041179-190XSpringer International Publishing Cham 3006973329610.1007/s40259-018-0296-zCorrectionCorrection to: GP2015: An Etanercept Biosimilar Deeks Emma D. demail@springer.com 0000 0004 0372 1209grid.420067.7Springer, Private Bag 65901, Mairangi Bay, Auckland, 0754 New Zealand 1 8 2018 1 8 2018 2018 32 5 525 525 © Springer Nature 2018Open AccessThis article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), which permits any noncommercial use, duplication, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license and indicate if changes were made.issue-copyright-statement© Springer Nature Switzerland AG 2018
==== Body
Correction to: BioDrugs 2018;31(6):555–558 10.1007/s40259-017-0246-1
The article GP2015: An Etanercept Biosimilar, written by Emma D. Deeks, was originally published Online First without open access. After publication in volume 31, issue 6, pages 555–558 HEXAL AG requested that the article be Open Choice to make the article an open access publication. Post-publication open access was funded by HEXAL AG. The article is forthwith distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), which permits any noncommercial use, duplication, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license and indicate if changes were made.

The original article has been corrected.

